United States: District Of New Jersey Dismisses Putative Securities Class Action Against Pharmaceutical Company For Failure To Adequately Allege Misrepresentations And Scienter - Shearman & Sterling LLP

United States: District Of New Jersey Dismisses Putative Securities Class Action Against Pharmaceutical Company For Failure To Adequately Allege Misrepresentations And Scienter - Shearman & Sterling LLP

Mondaq

Published

On August 4, 2022, the United States District Court for the District of New Jersey dismissed a putative securities class action asserting claims under the Securities Exchange Act of 1934...

Full Article